Disease Activity Measures and Outcomes in Rheumatoid Arthritis Randomized Clinical Trials versus “Routine Care”

On-Demand Audio Webcast

Jointly sponsored by University of Cincinnati and North American Center for Continuing Medical Education, LLC

Brought to you by

Presenter

Yusuf Yazici, MD
Assistant Professor of Medicine
 New York University School of Medicine
NYU Hospital for Joint Diseases
New York, New York

Target Audience

This self-directed performance improvement activity is designed for rheumatologists.

Learning Objectives

After completion of this activity, participants should be able to:

• Discuss the current use of outcome measures in rheumatoid arthritis (RA) management                              
• Summarize the role of early and aggressive treatment in RA management
• Describe the treat-to-target paradigm change in RA over the last 10 years: How to implement in routine care                       

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Release Date: December 29, 2009

Expiration Date: December 29, 2011  

Estimated time to complete: 1 hour

For questions regarding this activity, please call 609-371-1137.

 Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

University of Cincinnati designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Independent Clinical Reviewer: Mandana Hashefi, MD, Medical Faculty Associates, Division of Rheumatology, George Washington University, Washington, DC

Planning Committee

The planning committee comprises Yusuf Yazici, MD, Mandana Hashefi, MD; Kay Weigand, University of Cincinnati;  Randy Robbin, John Savage, Rosemary Hodgson, Greg Paladino, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of University of Cincinnati and NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of University of Cincinnati and NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Hashefi: Has disclosed no relevant relationships with any commercial interest
Dr. Yazici:  Grant/Research Support—Centocor, Inc.; Consultant—Bristol-Myers Squibb, Centocor, Inc., UCB, Inc., Roche, Celgene; Promotional Speakers’ Bureau—Bristol-Myers Squibb, UCB, Inc.

Ms. Weigand, Mr. Robbin, Mr. Savage, Ms. Hodgson, and Mr. Paladino have disclosed no relevant relationships with any commercial interest.
University of Cincinnati and NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices will be discussed.  The faculty has disclosed that no off-label/unapproved use of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting  purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC.  All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Amgen, Bristol-Myers Squibb, and Genentech